Key Inclusion Criteria:~* Consented to receive disclosure of their risk estimates to develop clinical symptoms
of AD based on their APOE genotype.~* Male or female, age 60 to 75 years inclusive. Females were to be
post-menopausal.~* Mini-Mental State Examination (MMSE) total score â‰¥ 24 and cognitively unimpaired as
evaluated by memory tests~* Homozygous APOE4 genotype.~* Participant willing to have a study partner.~Key
